Lynce, Filipa http://orcid.org/0000-0001-6615-7076
Nunes, Raquel
Article History
Accepted: 12 February 2021
First Online: 22 March 2021
Declarations
:
: Filipa Lynce has received research funding from Bristol-Myers Squibb, Pfizer, Tesaro, Immunomedics, Calithera Biosciences, Regeneron, and Inivata Ltd.; has received compensation from Bristol-Myers Squibb and Pfizer for service as a consultant; and has received non-financial support from Jounce Therapeutics. Raquel Nunes declares that she has no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by the authors.